The FDA March 31 authorized two rapid, at-home COVID-19 tests, a move advocates called a major breakthrough for at-home testing, The Hill reported.
The tests are Quidel's QuickVue and Abbott's BinaxNOW. Both allow users to swab themselves at home and get results in minutes. Quidel's test takes 10 minutes to get results, and Abbott's takes 15 minutes.
Testing advocates told The Hill the authorizations are a major breakthrough because the tests are simple, don't require a prescription and can be mass-produced by the two companies.
A spokesperson for Abbott told The Hill the company can make tens of millions of tests per month and plans to begin shipping them to major food, drug and mass merchandise retailers within weeks.
Read the full article here.